Cita APA

Shimada, T., Urakawa, I., Isakova, T., Yamazaki, Y., Epstein, M., Wesseling-Perry, K., . . . Jüppner, H. (2010). Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active. The Endocrine Society.

Chicago Style Citation

Shimada, Takashi, Itaru Urakawa, Tamara Isakova, Yuji Yamazaki, Michael Epstein, Katherine Wesseling-Perry, Myles Wolf, Isidro B. Salusky, i Harald Jüppner. Circulating Fibroblast Growth Factor 23 in Patients With End-Stage Renal Disease Treated By Peritoneal Dialysis Is Intact and Biologically Active. The Endocrine Society, 2010.

Cita MLA

Shimada, Takashi, et al. Circulating Fibroblast Growth Factor 23 in Patients With End-Stage Renal Disease Treated By Peritoneal Dialysis Is Intact and Biologically Active. The Endocrine Society, 2010.